Press Digest: British Business - June 10
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
Nuvalent jumps after GSK's $10.6 bln acquisition deal
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Toll Brothers, TG Therapeutics, CECO Environmental
U.S. STOCKS ON THE MOVE-Nuvalent, Sirius XM, J.M. Smucker
Brief: Nuvalent - To Pay $350.48 Million Termination Fee To Gsk If Agreement Terminated Under Certain Conditions - SEC Filing
GSK’s $11 bln cancer punt is worth the risk
Deals of the day-Mergers and acquisitions
Nuvalent jumps after GSK's $10.6 bln acquisition deal
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Brief: GSK CEO Says Don't Need Nuvalent Deal To Achieve £40 Bln Sales Target
UK's GSK falls on $10.6 bln Nuvalent deal to boost lung cancer portfolio
UK Stocks-Factors to watch on June 9 (updated)
GSK boosts cancer portfolio with $10.6 billion Nuvalent takeover (updated)
Brief: GSK To Acquire Nuvalent For $10.6 Billion
UK's GSK to buy US-based cancer drugmaker Nuvalent for $10.6 billion